Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Retinitis pigmentosa (RP) is a progressive retinal dystrophy characterized by rod–cone degeneration and night blindness. CERKL encodes a ceramide kinase–like protein selectively expressed in the retina. Mutations in CERKL were first linked to nonsyndromic autosomal recessive RP in Spanish families, establishing CERKL as RP26 (7 families, 9 affected) (PMID:18515597). Subsequent cohorts have confirmed its role across diverse populations.
Genetic studies in 272 Spanish RP families identified the recurrent nonsense variant c.769C>T (p.Arg257Ter) as the sole CERKL mutation in typical RP cases (PMID:21151602). In an Indian cohort, 14 unrelated RP patients harbored biallelic LoF variants including c.967_968del (p.Met323fs) and c.769C>T (p.Arg257Ter) (14 patients) (PMID:32865075). A founder splice‐site mutation c.238+1G>A was observed in seven Yemenite Jewish families (carrier frequency 4.4%) causing early macular involvement (7 families) (PMID:18055789). A nonsense variant c.847C>T in a consanguineous Pakistani pedigree further supports allelic heterogeneity (PMID:32411380). All reports fit an autosomal recessive inheritance model.
The variant spectrum in ARCERKL‐RP is dominated by recurrent truncating alleles: c.769C>T (p.Arg257Ter) across Spain, India, and Pakistan, c.967_968del (p.Met323fs) in Indian patients, and splice‐site c.238+1G>A in Yemenite Jews. Novel indels such as c.1045_1046delAT (p.Ile349fs) have also been described, underscoring loss‐of‐function as the primary mechanism.
Biochemical assays revealed that CERKL lacks detectable ceramide kinase activity; the R257X protein fails to localize to nucleoli and accumulates in the nucleus, suggesting destabilization of subcellular trafficking (PMID:15708351). Overexpression studies demonstrate that wild‐type CERKL protects cultured cells from oxidative‐stress–induced apoptosis, a function lost in the R257X mutant (PMID:19158957).
Proteomic analyses identified interactions between CERKL and neuronal calcium sensor proteins (GCAP1, GCAP2, recoverin) in a cation‐dependent manner, linking CERKL to phototransduction and calcium signaling pathways (PMID:22678504). These functional data concord with the human phenotype of photoreceptor degeneration.
No studies to date have refuted the CERKL–RP association or implicated alternative inheritance. The consistency of homozygous LoF variants in multiple cohorts and convergence of molecular assays meet criteria for a definitive gene–disease relationship.
In conclusion, biallelic truncating CERKL variants cause autosomal recessive retinitis pigmentosa through loss‐of‐function, with a characteristic early maculopathy. Genetic testing for recurrent alleles like c.769C>T (p.Arg257Ter) is recommended for molecular diagnosis, carrier screening, and selection of future gene‐based therapies.
Gene–Disease AssociationDefinitive
Genetic EvidenceStrongBiallelic truncating and splice-site CERKL variants identified in >25 families across multiple populations; autosomal recessive inheritance; recurrent founder alleles Functional EvidenceModerateLoss of kinase activity and nucleolar localization in R257X mutants; protective role against oxidative stress; interactions with phototransduction proteins |